Delta Injection Index as a Predictor of Visual Acuity Outcomes in Neovascular AMD patients in a Large Cohort with Long Term Follow-up
Abstract Purpose To investigate the change in Visual acuity (VA) of neovascular Age-related macular degeneration (nAMD) patients throughout three years of follow-up, according to the change in the number of annual anti vascular endothelial growth factor (VEGF) injections. Methods A retrospective, observational study of nAMD patients who were followed up between 06/2015-12/2021. Patients were divided into three groups based on the delta in the number of injections from baseline: no-delta, mid-delta, and high-delta. Results A total of 1,144 patients up met the inclusion criteria and were included in this study. Two hundred and twenty-six eyes were classified for the no-delta injections index group while 475 and 443 eyes were in the mid and high groups, respectively. Number of injections in the first year was similar between all three groups with 6.8 ± 2.3, 7.1 ± 2.0, and 6.9 ± 2.5 for the no-delta, mid-delta, and high-delta group (p = 0.345). Baseline VA was similar between all groups, 0.37 ± 0.31, 0.39 ± 0.31, and 0.41 ± 0.34 (p = 0.115), respectively. Final VA was significantly better for the no-delta group (p = 0.035), as the mid-delta and high-delta injection index groups suffered statistically significant decline in VA throughout three years down to 0.59 ± 0.46, and 0.61 ± 0.50, respectively (p < 0.01), while the no-delta patients experienced only a non-statistically significant decline in their VA to 0.50 ± 0.41 (p = 0.051). Conclusion Delta from baseline of annual anti-VEGF injections for nAMD patients may lead to less favorable visual outcomes with a statistically significant decline in visual acuity for the mid-delta and high delta groups in comparison to the no-delta group.
Authors
- Ram Cohen
- Eran Greenbaum (ORCID: https://orcid.org/0000-0002-1027-3139)
- Reut Shor
- Shai Cohen (ORCID: https://orcid.org/0009-0001-4046-2731)
- Gilad Rabina (ORCID: https://orcid.org/0000-0002-9206-8373)
- Ori Segal (ORCID: https://orcid.org/0000-0001-5701-9544)
- Omer Trivizki (ORCID: https://orcid.org/0000-0003-3887-6238)
- Anat Loewenstein (ORCID: https://orcid.org/0000-0002-7706-1165)
Institutions
- Tel Aviv Sourasky Medical Center (IL)
- Meir Medical Center (IL)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-16
- DOI
- https://doi.org/10.21203/rs.3.rs-10329065/v1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- preprint